@article{634fff8a1fdb450fbf265983e9abe3e0,
title = "Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET",
author = "Oprea-Lager, \{Daniela E.\} and Francesco Ceci and Matthias Eiber and Stefano Fanti and Ken Herrmann",
note = "Funding Information: Daniela E. Oprea-Lager reports unrestricted grants from Janssen for Consensus meetings attendance, outside the submitted work. Francesco Ceci declares no competing interests in relation with the submitted work. Matthias Eiber reports prior consulting activities for BED, Novartis, Telix, Progenics, Bayer, Point Biopharma, and Janssen and a patent application for rhPSMA, all outside the submitted work. Stefano Fanti reports personal fees from ANMI, Astellas, Bayer, Blue Earth Diagnostics, GE Healthcare, Janssen, Novartis, and Sofie Biosciences, and nonfinancial support from Advanced Accelerator Applications (AAA), Bayer, GE Health- care, Curium, Tema Sinergie, Sanofi, and Telix, outside the submitted work. Ken Herrmann reports personal fees from Bayer, SIR- TEX, Adacap, Curium, Endocyte, BTG, Ipsen, Siemens Healthineers, GE Healthcare, Amgen, Novartis, and Y-mAbs; stock options in Sofie Bio-sciences; nonfinancial support from ABX; and grants from BTG, outside the submitted work. ",
year = "2022",
month = dec,
doi = "10.1007/s00259-022-06007-0",
language = "English",
volume = "50",
pages = "10--11",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer",
number = "1",
}